EPISODE · Jul 10, 2020 · 22 MIN
The ESG Weekly: Pipelines are OVER; and are drug prices too high?
from Sustainability Now · host MSCI ESG Research LLC
A ruling by a US judge has put the entire oil and gas pipeline industry at risk in the US, and a lot of it is because companies have terrible community relations. And then, we discuss the price tag on Remdesivir, the first drug shown to be effective against the coronavirus ‐ and how drug prices affect company incentives.
Embed this episode
NOW PLAYING
The ESG Weekly: Pipelines are OVER; and are drug prices too high?
0:00
22:17
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Sustainability Now?
This episode is 22 minutes long.
When was this Sustainability Now episode published?
This episode was published on July 10, 2020.
Can I download this Sustainability Now episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!